Over the past few decades, substantial progress has been made to safely improve nerve function in spinal cord injury (SCI) patients through the regeneration of injured nerve tissue. This perspective focuses on an extensive overview of SCI research as well as tissue-engineered nerve regeneration for the treatment of SCI.
Get full access to this article
View all access options for this article.
References
1.
National Spinal Cord Injury Statistical Center. Spinal cord injury facts and figures at a glance. J Spinal Cord Med, 36, 1, 2013.
2.
OlbyN., HallingK.B., and GlickT.R.Rehabilitation for the neurologic patient. Vet Clin North Am Small Anim Pract, 35, 1389, 2005.
3.
HelkowskiW.M., DitunnoJ.F.Jr., and BoningerM.Autonomic dysreflexia: incidence in persons with neurologically complete and incomplete tetraplegia. J Spinal Cord Med, 26, 244, 2003.
4.
CholasR., HsuH., and SpectorM.Collagen scaffolds incorporating select therapeutic agents to facilitate a reparative response in a standardized hemiresection defect in the rat spinal cord. Tissue Eng Part A, 18, 2158, 2012.
5.
BurchielK.J., and HsuF.P.Pain and spasticity after spinal cord injury: mechanisms and treatment. Spine, 26, S146, 2001.
6.
SorkinL.S., and WallaceM.S.Acute pain mechanisms. Surg Clin North Am, 79, 213, 1999.
7.
TaghvaA., HohD.J., and LauryssenC.L.Advances in the management of spinal cord and spinal column injuries. Handb Clin Neurol, 109, 105, 2012.
8.
JuknisN., CooperJ.M., and VolshteynO.The changing landscape of spinal cord injury. Handb Clin Neurol, 109, 149, 2012.
9.
BlightA.R., and ZimberM.P.Acute spinal cord injury: pharmacotherapy and drug development perspectives. Curr Opin Investig Drugs, 2, 801, 2001.
10.
PriestleyJ.V., Michael-TitusA.T., and TetzlaffW.Limitingspinal cord injury by pharmacological intervention. Handb Clin Neurol, 109, 463, 2012.
11.
WillyardC.Stem cells: a time to heal. Nature, 503, S4, 2013.
12.
ChapmanA.R., and ScalaC.C.Evaluating the first-in-human clinical trial of a human embryonicstem cell-based therapy. Kennedy Inst Ethics J, 22, 243, 2012.
13.
GeffnerL.F., SantacruzP., IzurietaM., FlorL., MaldonadoB., AuadA.H., MontenegroX., GonzalezR., and SilvaF.Administration of autologous bone marrow stem cells into spinal cord injury patients via multiple routes is safe and improves their quality of life: comprehensive case studies. Cell Transplant, 17, 1277, 2008.
14.
TsukamotoA., UchidaN., CapelaA., GorbaT., and HuhnS.Clinical translation of human neural stem cells. Stem Cell Res Ther, 4, 102, 2013.
15.
NoriS., OkadaY., YasudaA., TsujiO., TakahashiY., KobayashiY., FujiyoshiK., KoikeM., UchiyamaY., IkedaE., ToyamaY., YamanakaS., NakamuraM., and OkanoH.Grafted human-induced pluripotent stem-cell-derived neurospheres promote motor functional recovery after spinal cord injury in mice. Proc Natl Acad Sci U S A, 108, 16825, 2011.
16.
van den BrandR., HeutschiJ., BarraudQ., DiGiovannaJ., BartholdiK., HuerlimannM., FriedliL., VollenweiderI., MoraudE.M., DuisS., DominiciN., MiceraS., MusienkoP., and CourtineG.Restoring voluntary control of locomotion after paralyzing spinal cord injury. Science, 336, 1182, 2012.
17.
BellJ.H., and HaycockJ.W.Next generation nerve guides: materials, fabrication, growth factors, and cell deliver. Tissue Eng Part B, 18, 116, 2012.
18.
JaklenecA., StampA., DeweerdE., SherwinA., and LangerR.Progress in the tissue engineering and stem cell industry “are we there yet?”. Tissue Eng Part B, 18, 155, 2012.
19.
DoornJ., MollG., Le BlancK., van BlitterswijkC., and de BoerJ.Therapeutic applications of mesenchymal stromal cells: paracrine effects and potential improvements. Tissue Eng Part B, 18, 101, 2012.
20.
CaplanA.I.Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol, 213, 341, 2007.
21.
SzpalskiC., BarbaroM., SagebinF., and WarrenS.M.Bone tissue engineering: current strategies and techniques-part II: cell types. Tissue Eng Part B, 18, 258, 2012.
22.
KangK.N., LeeJ.Y., KimD.Y., LeeB.N., AhnH.H., LeeB., KhangG., ParkS.R., MinB.H., KimJ.H., LeeH.B., and KimM.S.Regeneration of completely transected spinal cord using scaffold of poly(D,L-lactide-co-glycolide)/small intestinal submucosa seeded with rat bone marrow stem cells. Tissue Eng Part A, 17, 2143, 2011.
23.
KangK.N., KimD.Y., YoonS.M., LeeJ.Y., LeeB.N., KwonJ.S., SeoH.W., LeeI.W., ShinH.C., KimY.M., KimH.S., KimJ.H., MinB.H., LeeH.B., and KimM.S.Tissue engineered regeneration of completely transected spinal cord using human mesenchymal stem cells. Biomaterials, 33, 4828, 2012.
